Work

P087 Ileal Biomarker of Innate Immune Activation Can Predict Clinical Response to Vedolizumab in Crohn’s Disease

Year: 2019

Type: conference-abstract

Source: Gastroenterology

DOI: 10.1053/j.gastro.2019.01.148

Authors: Mark T. Osterman, Ilyssa O. Gordon, Elisabeth M. Davis, Matthew A. Ciorba, Sarah C. Glover, Bincy P. Abraham, Freeha Khan, Bo Shen, Eric Yee, Felicia Allard, Julia J. Liu

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2914807362

Cites:

Cited by:

Related to: 10